F(ab') 2 fragments, herein designated as F(ab') 2 fragments, were prepared from a mouse IgM monoclonal antibody specific to sialyl Lewis A antigen. The fragments were applied to flow cytometry to analyze the antigen on human cancer cells. The binding of the fragments to the antigen-positive cells was stronger than that of the original IgM. The non-specific binding of the IgM antibody to the antigen-negative cells was much decreased by using the F(ab') 2 fragments. These results indicate that the F(ab') 2 fragments are more suitable than the original IgM monoclonal antibody in flow cytometric analysis.
Introduction
Immuno-histochemical staining is useful for analysis of cancer cells because it allows us direct visualization of cancer-associated antigens on cell surfaces (Itai et al., 1990) . Flow cytometry is widely applied for cancer diagnoses and classification of leukocytes, although it is restricted by monoclonal antibodies (mAbs) which bind to the antigens.
Most of the hybridomas raised against cancerassociated antigens on cell surfaces so far reported are IgM producers. IgM molecules have a molecular mass of about 1000 kDa and a very low solubility, and this limits their application. Some efforts have been paid in order to overcome the difficulty in application of IgM. Screening class switch variants producing IgG mAbs from IgM-producing cells (Steplewski et al., 1985) and preparing single-chain antibodies by gene engineering (Winter and Milstein, 1991; Iba et al., 1995) are the examples. We have recently developed a convenient method for the preparation of F(ab') 2 fragments of 145 kDa from pepsin digests of mouse and rat IgM mAbs (Inouye and Morimoto, 1993a , 1993b , 1994 and suggested that the term F(ab') 2 should be used instead of F(ab') 2 to indicate that the fragments are prepared from IgM by cleaving the heavy chains. F(ab') 2 fragments were demonstrated to be suitable for enzyme-linked immunosorbent assays (ELISA), and the interaction of IgM mAb with non-specific proteins was greatly reduced, when it was converted to the fragments.
Sialyl Lewis A antigen (monosialyl, monofucosyllacto-N-tetraose; IV 3 NeuAc, III 4 Fuc-LcOse 4 ) is a well known tumor marker represented on cancer cells as glycolipids and glycoproteins (Koprowski et al., 1979; Magnani et al., 1982 Magnani et al., , 1983 and is utilized for diagnosis of gastrointestinal and pancreatic cancer (DelVillano et al., 1983) . We have raised a mouse hybridoma line producing an IgM mAb of anti-sialyl Lewis A. In this paper, we describe that F(ab') 2 fragments prepared from the IgM mAb are useful in flow cytometric analysis of sialyl Lewis A antigen represented on human cancer cells in comparison with the original IgM.
Materials and methods

Monoclonal antibody and cell lines
A mouse mAb SA23.2 (IgM class) specific to sialyl Lewis A antigen was used. A glycolipid fraction containing sialyl Lewis A antigen was purified from human meconium, and was used as the immunogen to a BALB/c mouse after being adsorbed to Salmonella minnesota (Fukushi et al., 1984) . A hybridoma line secreting mAb SA23.2 was established by fusing spleen cells from the immunized mouse with mouse SP2/0-Ag14 myeloma cells (Köhler and Milstein, 1975) . The hybridoma cells were injected into pristaneprimed BALB/c mice, and were grown in ascitic fluids (Morimoto and Inouye, 1992; Abe and Inouye, 1993) . The mAb was purified from the ascites by 60% ammonium sulfate saturation followed by gel filtration on TSKgel Toyopearl HW-55 (Tosoh, Tokyo, Japan) in 100 mM citrate buffer, pH 4.5 (Inouye, 1991; Inouye and Gohzu, 1991) . The purity of the mAb was examined by SDS-PAGE under reducing and non-reducing conditions and by gel filtration HPLC using TSKgel G4000SW XL . The specificity of mAb SA23.2 was examined by emzyme-linked immunosorbent assay (Hakomori and Kannagi, 1986) . mAb SA23.2 binds to sialyl Lewis A antigen but not to asialo or defucosylated forms of the antigen (see below, Immunoreactivity). The cell lines, Colo201 and SW1116 (human colon adenocarcinoma), Capan2 (human pancreas adenocarinoma), MKN74 (human stomach adenocarcinoma), and QG56 and PC9 (human lung carcinoma) were supplied from the American Type Culture Collection (Rockville, MD), and routinely maintained in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated FCS (Bioserum, Victoria, Australia), at 37 C in an atmosphere of 5% carbon dioxide.
Preparation of F(ab') 2 fragments
F(ab') 2 fragments of IgM mAb SA23.2 were prepared by the method previously reported (Inouye and Morimoto, 1993a) . The IgM was digested with pepsin at a pepsin-to-IgM ratio of 1:200 (w/w) in 100 mM citrate buffer, pH 4.2, at 37 C for 2 h. F(ab') 2 fragments were purified to the homogeneity by high-peformance liquid chromatography (HPLC) using TSKgel Ether-5PW (Tosoh) (Inouye and Morimoto, 1993a) .
Preparation of FITC-conjugates of mAb and F(ab') 2
Conjugation of IgM and F(ab') 2 with FITC (Dojindo, Kumamoto, Japan) was performed by the method previously reported (Maeda et al., 1969; Johnson and Holborrow, 1986) . The conjugates were separated from free FITC by gel filtration HPLC on a TSKgel G4000SW XL column (7.8 mm (inner diameter) 30 cm) (Tosoh) with PBS (pH 7.4) at a flowrate of 1 ml/min. The collected fraction was applied again to HPLC under the same conditions. The FITCconjugates of mAb and F(ab') 2 eluted in a single peak at 7.7 and 11.0 min, respectively. Fractions of 0.5 ml were collected and stored at 4 C in the dark with 0.05% (w/v) sodium azide until use. The concentrations of mAb and F(ab') 2 were determined by the absorption coefficient A 280 (l mg ml 1 ) of 1.4, and that of FITC was by the molar absorption coefficient 495 of 67,600. Numbers of fluorescein moiety bound to the mAb and the F(ab') 2 molecules were determined to be 4.9 and 1.2, respectively, by the following equation (Johnstone and Thorpe, 1996) :
FITC/protein molar ratio = 2.87 A 495 (A 280 -0.35 A 495 ), by using the absorbances of the conjugates at 280 and 495 nM.
Preparation of alkaline phosphatase-conjugates of mAb and F(ab') 2
Bovine intestine alkaline phosphatase (type VII-S) was purchased from Sigma (St. Louis, MO). A 2-ml enzyme solution (2 mg ml 1 ) in PBS was incubated with 20 l of N-succinimidyl-3-(2'-pyridyldithio)propionate (SPDP) (5 mg ml 1 ) at 4 C for 16 h, followed by dialysis at 4 C. A 2-ml solution of mAb or the fragments (2 mg ml 1 ) in PBS was treated with 30 l S-acetylmercapto-succinic anhydride (SAMSA) (10 mg ml 1 ) at 37 C for 1 h, followed by dialysis at 4 C. The alkaline phosphatase treated with SPDP and the mAb or F(ab') 2 treated with SAM-SA were mixed with 50 l of 1 M NH 2 OH at 4 C for 1 day. The reaction mixture was applied to gel filtration HPLC on a TSKgel G3000SW XL (7.5 mm (inner diameter) 60 cm) at a flow-rate of 1.0 ml min 1 , and the conjugates were separated from the free enzymes. The elution was detected by absorption at 280 nM.
The numbers of the enzyme molecules bound to the mAb and F(ab') 2 were determined to be 3.5 and 1.1 (mole/mole), respectively, by gel filtration HPLC. The molecular mass of the enzyme-F(ab') 2 conjugate was estimated to be 260 kDa, suggesting that 1.1 moles of the enzyme (dimer of 50 kDa subunits) were conjugated with a mole of the fragment (145 kDa). When the same amount of F(ab') 2 in the free state or in the enzyme-F(ab') 2 conjugate was applied to gel filtration HPLC, the peak area of the conjugate was 1.8 times larger than that of the free F(ab') 2 . This means that the molecular mass of the conjugate is 1.8 times larger than that of the fragment, by assuming the same absorption coefficient, A 280 (1 mg ml 1 ) for both F(ab') 2 and enzyme-F(ab') 2 conjugate. This leads to an estimation that 1.2 moles of the enzyme (dimer of 50 kDa subunits) are conjugated to a mole of F(ab') 2 . The molar ratio of the enzyme to F(ab') 2 is in good agreement with the value 1.1 estimated from eluation volume in HPLC.
The enzyme-mAb conjugate as well as the mAb itself eluted at the void volume in the gel filtration HPLC, being separated from the free enzyme. As the molecular mass of the conjugate could not be estimated from the elution volume, the peak areas in the gel filtration HPLC of the same amount of mAb in the free state or in the enzyme-mAb conjugate were compared. The peak area of the conjugate was 1.35 times larger than that of the free mAb. By assuming the absorption coefficient, A 280 (1 mg ml 1 ) of the mAb and the conjugate to be the same, the molecular mass of the conjugate was estimated to be 1,350 kDa, suggesting that 3.5 moles of the enzyme were conjugated with one mole mAb.
The enzyme activity of the conjugates was determined using hydrolysis of p-nitrophenyl phosphate (pNPP) in 50 mM carbonate buffer (pH 9.5) containing 10 mM MgCl 2 . Concentrations of the conjugates and the enzyme were determined by using an absorption coefficient, A 280 (1 mg ml 1 ) of 1.4, and molecular masses of the enzyme (100 kDa), enzyme-mAb conjugate (1,350 kDa) and enzyme-F(ab') 2 conjugate (260 kDa). The catalytic constants kcat and Michaelis constant Km of the enzyme were determined to be 48 s 1 and 1.8 mM, respectively; those of the enzyme-mAb conjugate were 123 s 1 and 1.8 mM, and of enzyme F(ab') 2 conjugate 22 s 1 and 2.0 mM, respectively. As the enzyme-mAb and enzyme-F(ab') 2 conjugates contain 3.5 and 1.1 enzyme moles in a mole of the conjugates, the kcat values calculated on the basis of the enzyme concentration might be 35 and 20 s 1 , respectively. Namely, the catalytic activities of the enzyme bound to the mAb and F(ab') 2 are 73 and 42% of that of the free enzyme, respectively, although the Km values are not changed by the conjugation.
Immunoreactivity
Immunoreactivity of mAb SA23.2 and its F(ab') 2 fragments against CA19-9, a serum mucin containing sialyl Lewis A antigen, was measured by means of sandwich enzyme immunoassay. CA19-9 was obtained from Centocor (Malvern, PA) and determined by using their radioimmunoassay kits. A microtiter plate (96 wells; Nunc-Intermed, MaxiSorp; Roskilde, Denmark) was coated with mAb SA23.2 (100 l of 2 g ml 1 in 50 mM sodium carbonate buffer, pH 9.5, in each well) and incubated at 37 C for 1 h. Plates were blocked by incubation with 0.2% bovine serum albumin (BSA) in PBS (pH 7.4) overnight at 4 C. After washing the plate PBS, the plate was incubated with CA19-9 at various concentrations (0, 25, 100, 200 and 400 U ml 1 ) in 100 ml PBS containing 0.2% BSA at 37 C for 1 h. The plate was washed again with PBS and incubated with 100
l of 2 g ml 1 alkaline phosphatase conjugates with mAb SA23.2 or F(ab') 2 fragments at 37 C for 1 h.
The plate was washed again with PBS, followed by adding 100 l of the substrate solution (1 mg ml 1 pnitrophenyl phosphate in 50 mM carbonate buffer pH 9.5, containing 10 mM MgCl 2 ). Absorbance at 405 nM was measured after the reaction for 20 min at 37 C.
The specificity of mAb SA23.2 was examined by inhibition assay with three carbohydrate antigens, monosialyl, monofucosyllacto-N-tetraose (IV 3 NeuAc, III 4 Fuc-LcOse 4 ), lacto-N-fucopentaose II (III 4 FucLcOse 4 ), and sialyllacto-N-tetraose a (IV 3 NeuAcLcOse 4 ), purchased from BioCarb Chemicals, Lund, Sweden) (Hakomori and Kannagi, 1986) . A hundred l of the antigen at various concentrations (0, 0.6, 5, 25, 100 and 500 g ml 1 ) was added to the mAb SA23.2-coated well prepared as above, and incubated with 100 l of 2 g ml 1 enzyme-mAb conjugate and 240 U ml 1 of CA19-9 at 37 C for 1 h. The specificity of mAb SA23.2 was measured by means of the sandwich enzyme immunoassay described above. The inhibitory activity of the carbohydrate antigen was estimated by comparing the absorbance at 405 nM observed in the presence of the carbohydrate antigen (inhibitor) with that observed in the absence. Figure 1 . The immunoreactivity of IgM mAb SA23.2 and its F(ab') 2 fragments with CA19-9. Each well of a 96-well microtiter plate was coated with mAb SA23.2by adding 100 l mAb SA23.2 solutions (2 g/ml). A hundred l of CA19-9 solution at the concentration indicated on the abscissa was added to the well, followed by the addition of 100 l of 2 g ml 1 alkaline phosphatase conjugates of IgM mAb SA23.2 () and its F(ab') 2 fragments ().
Absorbance at 405 nM generated by the reaction with p-nitrophenyl phosphatase for 20 min at 37 C was observed. Mean values of the triplicate measurements were plotted.
Immunofluoresecent staining
For staining of Colo201, SW1116, Capan2, MKN74, PC9, and QG56 cells, 20 l of FITC conjugates of mAb SA23.2 or its F(ab') 2 fragnents was mixed with 10 6 cells suspended in 100 l of PBS containing 10% FCS, and incubated at 37 C for 10 min. Free conjugates were removed by washing the cells twice with PBS by centrifugation at 4000 g for 5 min. The cells were resuspended again in PBS, and applied to flow cytometry at 37 C.
Flow cytometry
Flow cytometry was performed using a FACStar plus flow cytometer (Becton Dickinson, San Jose, CA) equipped with an argon laser and a FACStar research software. Cells were excited at 488 nM and FITC emission was detected with a 53030 nM bandpass filter. Fluorescence data were displayed on four-decade log scales. Ten thousands or more data were collected for each analysis. 
Results and discussion
Immunoreactivity
Immunoreactivity of mAb SA23.2 and the F(ab') 2 fragments to CA19-9 antigen is shown in Fig. 1 . A standard curve was obtained in the CA19-9 concentration ranging from 0 to 400 U ml 1 . The immunoreactivity of mAb SA23.2 is 1.45 times larger than that of the F(ab') 2 fragments. As all measurements of enzyme activity were carried out under the conditions that substrate concentration was in large excess over the Michaelis constant Km (1.8 mM), the reaction velocity must be the maximum velocity, Vmax. Assuming that the same amount of enzyme was bound to the CA19-9 antigen captured on the plate when the enzyme conjugates of mAb and F(ab') 2 fragments were used as the second antibody, the enzyme activity of the enzymemAb conjugate would be 1.75 times larger than that of the enzyme-F(ab') 2 conjugate. Therefore, enzyme molecules bound onto the plates with the enzyme-mAb conjugates could be 83% of that with the enzyme-F(ab') 2 conjugate and that the number of the F(ab') 2 fragments bound onto the plate is 3.8 times larger than that of the mAb. Figure 2 demonstrates that monosialyl, monofucosyllacto-N-tetraose inhibits the binding of mAb SA23.2 with CA19.9, however, lacto-N-fucopentaose II and sialyllacto-N-tetraose a show no significant inhibition. The similar inhibitory effect was observed on the binding between F(ab') 2 and CA19-9 (data not shown). This indicates that both sialyl and fucosyl groups of sialyl Lewis A antigen are essential in the recognition of CA19-9 by mAb SA23.2 and the F(ab') 2 fragments.
Flow cytometry
Flow cytometry of MKN74, QG56 and PC9 cells, being sialyl Lewis A-negative, was examined by staining them with FITC conjugates of mAb SA23.2 and its F(ab') 2 fragments. No staining of PC9 (Fig. 3A ) and MKN74 cells (data not shown) was observed with both conjugates, and for QG56 cells (Fig. 3B ), 3 and 25% of the total population were stained with FITC-F(ab') 2 and FITC-mAb conjugates, respectively. It was also shown that 20-25% of the QG56 cell population was stained even with the FITC conjugates of nonspecific IgM mAbs (data not shown). This suggests that mAb SA23.2 binds QG56 cells non-specifically, and the non-specific binding is reduced drastically from 25 to 3% by using F(ab') 2 fragments in place of IgM mAb. Figure 3C shows the staining of Colo201 cells, which are sialyl Lewis A-positive, by FITC conjugates of mAb SA23.2 and the F(ab') 2 fragments. All Colo201 cells were stained with both conjugates, and the fluorescence intensity induced with FITC-F(ab') 2 was 5 times higher than that with FITC-mAb. Numbers of FITC molecules conjugated on mAb and F(ab') 2 fragments are 4.9 and 1.2, respectively. Relative fluorescence intensities of FITC conjugates of mAb and F(ab') 2 were almost proportional to the numbers of FITC molecules carried on the respective proteins, and thus the quantum yield of FITC on both molecules is considered to be reasonably the same. If the same numbers of mAb and F(ab') 2 molecules were bound to the cells, fluorescence intensity of FITC conjugates with mAb might be 4.1 times higher than that with F(ab') 2 , although it was actually 1/5th. Accordingly, the number of F(ab') 2 molecules bound on the cells is estimated to be 21 times greater than that of mAb. These lines of evidence suggest that the FITCmAb conjugate cannot bind densely to the CA19-9 antigens expressed on the surface of Colo201, probably because of its large size and steric hindrance. On Figure 3A .
the other hand, the FITC-F(ab') 2 conjugate, which is 1/5th the size of the FITC-mAb, can bind the cells more densely than the FITC-mAb. Distribution of the cells stained with FITC-F(ab') 2 was narrower than that with FITC-mAb, suggesting that the binding of F(ab') 2 fragments to Colo201 cells is stronger and more specific than that of mAb SA23.3 (Fig. 3C) . Flow cytometric analysis of SW1116 and Capan2 showed the similar results to that of Colo201. These cells were stained by both FITC conjugates of mAb and F(ab') 2 . The fluorescence intensities of SW1116 and Capan2 cells induced with the FITC-F(ab') 2 conjugates were 5 and 4 times higher than that with the FITC-mAb conjugates, respectively.
Usefulness of F(ab') 2 fragments in the enzyme immunoassays
F(ab') 2 fragments have been shown to be superior to their original IgM mAb as a staining reagent of sialyl Lewis A antigen on cell surfaces by means of flow cytometry. This might be explained in several ways. F(ab') 2 fragments may bind the antigens expressed on cellular membranes more easily than IgM because of their smaller molecular size; 145 kDa for the fragments and 1,000 kDa for IgM. The sugar content of F(ab') 2 fragments is much reduced as compared with that of IgM, because of the loss of the Fc region being abundant in sugar residues, which may lead to less non-specific binding (Inouye and Morimoto, 1993a) . The binding of IgG and IgM mAbs to non-specific proteins in enzyme immunoassay is greatly reduced by using the F(ab') 2 fragments instead of the whole mAb molecules (Morimoto and Inouye, 1992; Inouye and Morimoto, 1993a, 1994) . In the present study, it has been also demonstrated that the smaller molecular size and reduced sugar content of F(ab') 2 fragments seem to make them more useful as a staining reagent in flow cytometry. Recently, single-chain antibody containing only the Fv region of mAb has been expressed in E. coli, the molecular size of which is around 20 kDa and the sugar content zero (Winter and Milstein, 1991, Iba et al., 1995) . However, preparing single-chain antibody required genetic engineering techniques, and it is time-consuming compared to the preparation of F(ab') 2 fragments. F(ab') 2 fragments provides us which the higher sensitivity and specificity in flow cytometric analysis than IgM mAb, and they can be useful to determine the antigens presented on cell surfaces.
Conclusion
Monoclonal antibodies are of great interest in diagnosis and therapy. IgG mAbs are mainly used, and IgMs have been avoided possibly of difficulties in handling. mAbs raised against cancer-associated sugar antigens could be useful for cancer diagnosis and therapy. However, almost all mAbs so far reported are of the IgM-class. We have reported a convenient method for preparing active fragments of IgM, and showed that the fragments could be used in ELISA reactions better than using IgM (Inouye and Morimoto, 1993a , 1993b , 1994 . F(ab') 2 fragments prepared from mouse IgM mAb SA23.2 specific to sialyl Lewis A antigen were applied to flow cytometry to analyze the antigen on human cancer cells. The binding of the fragments to the antigenpositive cells was stronger than that of the original IgM, and the non-specific binding of the IgM antibody to the antigen-negative cells was much decreased by using the F(ab') 2 fragments. These results indicate that the F(ab') 2 fragments are more suitable than the original IgM mAb in flow cytometry as well as in ELISA.
